Joy Artin, Yumn A. Elsabagh, Laila Rashed, and Mohamed A. Hussein, “Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations”, Archives of Rheumatology, vol. 38, no. 2, pp. 249–256, Jun. 2023.